229 related articles for article (PubMed ID: 10529591)
1. A novel assay for serum complement activity: C42 generation assay.
Kobayashi E; Kitano E; Kitamura H
Int Arch Allergy Immunol; 1999 Sep; 120(1):71-7. PubMed ID: 10529591
[TBL] [Abstract][Full Text] [Related]
2. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
3. Classical pathway evaluation.
Giclas PC
Curr Protoc Immunol; 2001 May; Chapter 13():Unit 13.1. PubMed ID: 18432714
[TBL] [Abstract][Full Text] [Related]
4. Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.
Ekdahl KN; Norberg D; Bengtsson AA; Sturfelt G; Nilsson UR; Nilsson B
Clin Vaccine Immunol; 2007 May; 14(5):549-55. PubMed ID: 17344343
[TBL] [Abstract][Full Text] [Related]
5. Testing of hemolytic complement components in domestic animals.
Barta O; Hubbert NL
Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
[TBL] [Abstract][Full Text] [Related]
6. A hemolytic method for the measurement of nephritic factor.
West CD
J Immunol Methods; 2008 Jun; 335(1-2):1-7. PubMed ID: 18410942
[TBL] [Abstract][Full Text] [Related]
7. Sheep Erythrocyte Preparation for Hemolytic Tests Exploring Complement Functional Activities.
Chabannes M; Bordereau P; Martins PV; Dragon-Durey MA
Methods Mol Biol; 2021; 2227():61-67. PubMed ID: 33847931
[TBL] [Abstract][Full Text] [Related]
8. [Components of the classical complement pathway in systemic lupus erythematosus].
Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
[TBL] [Abstract][Full Text] [Related]
9. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
10. Alternative complement pathway activation by C4b deposited during classical pathway activation.
Matsushita M; Okada H
J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
[TBL] [Abstract][Full Text] [Related]
11. Accelerated decay of the cell bound C4b2a complex by serum of patients with membranoproliferative glomerulonephritis and acute poststreptococcal glomerulonephritis.
Tanuma Y; Ohi H; Hatano M
Clin Immunol Immunopathol; 1992 Mar; 62(3):270-6. PubMed ID: 1541053
[TBL] [Abstract][Full Text] [Related]
12. The bovine complement system.
Linscott WD; Triglia RP
Adv Exp Med Biol; 1981; 137():413-30. PubMed ID: 7331946
[TBL] [Abstract][Full Text] [Related]
13. Studies of Pig Complement: Measurement of Pig CH50, ACH50, and Components.
Sakai R; Kitano E; Hatanaka M; Lo P; Matsuura R; Deguchi K; Eguchi H; Maeda A; Watanabe M; Matsunari H; Nagashima H; Okuyama H; Miyagawa S
Transplant Proc; 2016 May; 48(4):1282-4. PubMed ID: 27320604
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic complement activity in normal human donor corneas.
Mondino BJ; Hoffman DB
Arch Ophthalmol; 1980 Nov; 98(11):2041-4. PubMed ID: 7002126
[TBL] [Abstract][Full Text] [Related]
15. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
16. A study of complement components C3, C5, C6, C7, C8 and C9 in chronic membranoproliferative glomerulonephritis, systemic lupus erythematosus, poststreptococcal nephritis, idiopathic nephrotic syndrome and anaphylactoid purpura.
Geiger H; Good RA; Day NK
Z Kinderheilkd; 1975; 119(4):269-78. PubMed ID: 49134
[TBL] [Abstract][Full Text] [Related]
17. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
18. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia--simultaneous occurrence with free C3 NeF.
Wahn V; Müller W; Rieger C; Rother U
Pediatr Res; 1987 Aug; 22(2):123-9. PubMed ID: 3658535
[TBL] [Abstract][Full Text] [Related]
19. Assessment of complement activation in clinical samples. Comparison of immunochemical and functional measurements of complement components with quantitation of activation fragments.
Maillet F; Frémeaux-Bacchi V; Uhring-Lambert B; Kazatchkine MD
J Immunol Methods; 1992 Dec; 156(2):171-8. PubMed ID: 1474254
[TBL] [Abstract][Full Text] [Related]
20. A novel ELISA for the evaluation of the classical pathway of complement.
Zwirner J; Wittig A; Kremmer E; Götze O
J Immunol Methods; 1998 Feb; 211(1-2):183-90. PubMed ID: 9617842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
